loading
Precedente Chiudi:
$2.80
Aprire:
$2.79
Volume 24 ore:
51,047
Relative Volume:
0.11
Capitalizzazione di mercato:
$6.08M
Reddito:
-
Utile/perdita netta:
$-7.77M
Rapporto P/E:
-0.2807
EPS:
-9.9046
Flusso di cassa netto:
$-6.52M
1 W Prestazione:
-4.14%
1M Prestazione:
+28.70%
6M Prestazione:
-54.05%
1 anno Prestazione:
-72.88%
Intervallo 1D:
Value
$2.70
$2.89
Intervallo di 1 settimana:
Value
$2.5701
$2.98
Portata 52W:
Value
$1.31
$18.90

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
Nome
Adial Pharmaceuticals Inc
Name
Telefono
434-422-9800
Name
Indirizzo
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
Dipendente
6
Name
Cinguettio
@AdialPharma
Name
Prossima data di guadagno
2026-08-12
Name
Ultimi documenti SEC
Name
ADIL's Discussions on Twitter

Compare ADIL vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ADIL icon
ADIL
Adial Pharmaceuticals Inc
2.78 6.08M 0 -7.77M -6.52M -9.9046
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
485.39 123.19B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
664.52 69.67B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
877.62 54.58B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
298.76 39.89B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
186.88 39.73B 742.00K -1.37B -1.07B -7.0731

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-14 Iniziato Rodman & Renshaw Buy
2018-10-30 Iniziato Maxim Group Buy
2018-10-11 Iniziato Dawson James Buy

Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie

pulisher
Jul 04, 2026

Price to earnings forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

Jul 04, 2026
pulisher
Jul 01, 2026

Coastlands Group takes 14.22% position in Adial Pharmaceuticals (ADIL) - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Enterprise value to EBIT forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria

Jul 01, 2026
pulisher
Jul 01, 2026

Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals - Investing.com

Jul 01, 2026
pulisher
Jul 01, 2026

Form 4 Adial Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026
pulisher
Jul 01, 2026

Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Price to book forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

Enterprise value to revenue forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

Jul 01, 2026
pulisher
Jun 29, 2026

Adial Pharmaceuticals (ADIL) Gains 1.17% as Shares Approach Key Resistance LevelMFI Oversold - dars.gov.et

Jun 29, 2026
pulisher
Jun 29, 2026

Coastlands Capital details ADIAL Pharmaceuticals (ADIL) stock and warrant stake - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Insider Conviction: Why Coastlands Capital is Buying Adial Pharmaceuticals Ahead of a Pivotal Phase 3 - Kavout | AI

Jun 29, 2026
pulisher
Jun 25, 2026

ADIL stock eyes best day in over 5 years — major pipeline overhaul and $64M raise fuel rally - MSN

Jun 25, 2026
pulisher
Jun 25, 2026

Adial Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ADIL) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

ADIL Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Coastlands files 9.98% holding in Adial Pharmaceuticals (ADIL) - Stock Titan

Jun 24, 2026
pulisher
Jun 22, 2026

ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally - Stocktwits

Jun 22, 2026
pulisher
Jun 22, 2026

Adial Pharmaceuticals Inc (ADIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026
pulisher
Jun 19, 2026

Net current asset value per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

Jun 19, 2026
pulisher
Jun 18, 2026

Adial Pharmaceuticals Inc (ADIL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adial Pharmaceuticals Inc (ADIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

Adial closes $32 million financing, grants stock to new executives By Investing.com - Investing.com South Africa

Jun 16, 2026
pulisher
Jun 16, 2026

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing - The Manila Times

Jun 16, 2026
pulisher
Jun 16, 2026

Adial Pharmaceuticals (ADIL) CDO adds RSUs, options and preferred shares after Azora merger - Stock Titan

Jun 16, 2026
pulisher
Jun 16, 2026

ADIAL (ADIL) director and CDO Matt Davidson listed in Form 3 filing - Stock Titan

Jun 16, 2026
pulisher
Jun 16, 2026

Adial Pharmaceuticals (NASDAQ: ADIL) director buys 36,378 pre-funded warrants - Stock Titan

Jun 16, 2026
pulisher
Jun 16, 2026

ADIAL (ADIL) director Wendy Young files initial insider Form 3 statement - Stock Titan

Jun 16, 2026
pulisher
Jun 16, 2026

Adial closes $32 million financing, grants stock to new executives - Investing.com

Jun 16, 2026
pulisher
Jun 15, 2026

ADIL Initiates Coverage by LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus

Jun 15, 2026
pulisher
Jun 15, 2026

ADIL Initiates Coverage by LUCID CAPITAL MARKETS -- Rating Set to Buy - GuruFocus

Jun 15, 2026
pulisher
Jun 15, 2026

Lucid Capital Markets initiates Adial Pharmaceuticals stock with buy rating on colitis drug potential - Investing.com UK

Jun 15, 2026
pulisher
Jun 13, 2026

Adial Pharmaceuticals (ADIL) Holds Steady at $2.98 as Consolidation NarrowsIchimoku Kumo Twist - newsline.com

Jun 13, 2026
pulisher
Jun 12, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Jun 12, 2026
pulisher
Jun 12, 2026

Adial broadens pipeline with Azora acquisition and up to $64 million financing - The Pharma Letter

Jun 12, 2026
pulisher
Jun 12, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jun 12, 2026
pulisher
Jun 11, 2026

Top Midday Gainers - Moomoo

Jun 11, 2026
pulisher
Jun 11, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Jun 11, 2026
pulisher
Jun 11, 2026

Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics and Sec - GuruFocus

Jun 11, 2026
pulisher
Jun 11, 2026

Adial Pharmaceuticals acquires Azora Therapeutics, secures up to $64M financing - MSN

Jun 11, 2026
pulisher
Jun 11, 2026

Top movers analysis one hour before the close of the markets on 2026-06-11: top gainers and losers in today's session. - ChartMill

Jun 11, 2026
pulisher
Jun 11, 2026

Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics to Enha - GuruFocus

Jun 11, 2026
pulisher
Jun 11, 2026

Adial Pharmaceuticals Announces Acquisition Of Azora Therapeutics And Up To $64 Million Financing - TradingView

Jun 11, 2026
pulisher
Jun 11, 2026

Adial Pharmaceuticals, Inc. (ADIL) Stock: Strategic Acquisition Positions Company for Clinical Growth - parameter.io

Jun 11, 2026
pulisher
Jun 11, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jun 11, 2026

Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$56.43
price down icon 2.64%
$115.61
price down icon 2.24%
$35.97
price down icon 2.28%
$68.27
price down icon 10.83%
ONC ONC
$298.70
price down icon 1.36%
$186.88
price down icon 2.22%
Capitalizzazione:     |  Volume (24 ore):